 | Up a level |
Journal Article
Alawbathani, Salem, Batool, Mehreen, Fleckhaus, Jan, Hamad, Sarkawt 
ORCID: 0000-0002-5155-9467, Hassenrueck, Floyd, Hou, Yanhong, Li, Xia ORCID: 0000-0001-7765-0333, Salmanton-Garcia, Jon, Ullah, Sami, Wieters, Frederique and Michel, Martin C.
(2021).
A teaching tool about the fickle p value and other statistical principles based on real-life data.
Naunyn-Schmiedebergs Arch. Pharmacol., 394 (6).
S. 1315 - 1320.
NEW YORK:
SPRINGER.
ISSN 1432-1912
Goeckeritz, Elisa, Vondey, Verena, Guastafierro, Anna, Pizevska, Maja, Hassenrueck, Floyd, Neumann, Lars, Hallek, Michael and Krause, Guenter (2017). Establishing a chemical genetic link between Bruton tyrosine kinase activity in malignant B cells and cell functions involved in the micro-environmental dialogue. Br. J. Haematol., 178 (6). S. 949 - 954. HOBOKEN: WILEY. ISSN 1365-2141
Hassenrueck, Floyd, Knoedgen, Eva, Goeckeritz, Elisa, Midda, Safi Hasan ORCID: 0000-0002-2822-6293, Vondey, Verena, Neumann, Lars, Herter, Sylvia, Klein, Christian ORCID: 0000-0001-7594-7280, Hallek, Michael and Krause, Guenter
(2018).
Sensitive Detection of the Natural Killer Cell-Mediated Cytotoxicity of Anti-CD20 Antibodies and Its Impairment by B-Cell Receptor Pathway Inhibitors.
Biomed Res. Int., 2018.
LONDON:
HINDAWI LTD.
ISSN 2314-6141
Krause, Guenter, Hassenrueck, Floyd and Hallek, Michael (2020). Cell line-based assessment of BTK inhibitors. Br. J. Pharmacol., 177 (9). S. 2163 - 2166. HOBOKEN: WILEY. ISSN 1476-5381
Krause, Guenter, Hassenrueck, Floyd and Hallek, Michael (2018). Copanlisib for treatment of B-cell malignancies: the development of a PI3K inhibitor with considerable differences to idelalisib. Drug Des. Dev. Ther., 12. S. 2577 - 2591. ALBANY: DOVE MEDICAL PRESS LTD. ISSN 1177-8881
Krause, Guenter ORCID: 0000-0003-3905-0921, Hassenrueck, Floyd and Hallek, Michael
(2020).
Relevant Cytokines in the B Cell Lymphoma Micro-Environment.
Cancers, 12 (9).
BASEL:
MDPI.
ISSN 2072-6694